{{Rsnum
|rsid=9557635
|Gene=NALCN
|Chromosome=13
|position=101398739
|Orientation=plus
|GMAF=0.2309
|Gene_s=NALCN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 22.1 | 47.8 | 30.1
| HCB | 0.7 | 21.9 | 77.4
| JPT | 2.7 | 23.0 | 74.3
| YRI | 0.0 | 9.5 | 90.5
| ASW | 0.0 | 15.8 | 84.2
| CHB | 0.7 | 21.9 | 77.4
| CHD | 3.7 | 23.9 | 72.5
| GIH | 10.9 | 42.6 | 46.5
| LWK | 0.9 | 13.6 | 85.5
| MEX | 6.9 | 34.5 | 58.6
| MKK | 3.8 | 28.2 | 67.9
| TSI | 11.8 | 58.8 | 29.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23144319
  |Trait=Non-small cell lung cancer
  |Title=Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
  |RiskAllele=A
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}